EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:69228 - caerulomycin I
| Formula | C13H13N3O3 |
| Net Charge | 0 |
| Average Mass | 259.265 |
| Monoisotopic Mass | 259.09569 |
| SMILES | CONC(=O)c1cc(OC)cc(-c2ccccn2)n1 |
| InChI | InChI=1S/C13H13N3O3/c1-18-9-7-11(10-5-3-4-6-14-10)15-12(8-9)13(17)16-19-2/h3-8H,1-2H3,(H,16,17) |
| InChIKey | JYJANIYSNABJRT-UHFFFAOYSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Actinoalloteichus cyanogriseus (ncbitaxon:65497) | - | PubMed (21770434) | Ethyl acetate extract of fermentation broth Strain: WH1 2216-6 |
| Roles Classification |
|---|
| Biological Roles: | marine metabolite Any metabolite produced during a metabolic reaction in marine macro- and microorganisms. bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| caerulomycin I (CHEBI:69228) has parent hydride 2,2'-bipyridine (CHEBI:30351) |
| caerulomycin I (CHEBI:69228) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin I (CHEBI:69228) has role bacterial metabolite (CHEBI:76969) |
| caerulomycin I (CHEBI:69228) has role marine metabolite (CHEBI:76507) |
| caerulomycin I (CHEBI:69228) is a aromatic ether (CHEBI:35618) |
| caerulomycin I (CHEBI:69228) is a bipyridines (CHEBI:50511) |
| caerulomycin I (CHEBI:69228) is a pyridine alkaloid (CHEBI:26416) |
| caerulomycin I (CHEBI:69228) is a pyridinecarboxamide (CHEBI:25529) |
| IUPAC Name |
|---|
| N,4-dimethoxy-2,2'-bipyridine-6-carboxamide |
| Registry Numbers | Sources |
|---|---|
| Reaxys:21856155 | Reaxys |
| Citations |
|---|